Drug intelligence / Profile preview

Tinospora crispa extract

Development stage
Phase 3
Modality
Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
Administration
Oral, Topical
01

Overview

Tinospora crispa extract is a natural plant-derived substance used in traditional medicine systems across Asia. It's obtained from the stems of *Tinospora crispa (L.) Hook. f. & Thomson*, a plant belonging to the Menispermaceae family that grows in rainforests and mixed deciduous forests in Asia and Africa[2]. ## Composition and Active Compounds The extract contains several bioactive compounds including: - Alkaloids - Flavonoids and flavone glycosides - Triterpenes and diterpenes - Diterpene glycosides - Cis clerodane-type furanoditerpenoids - Lactones - Sterols - Lignans - Nucleosides[2] Phytochemical analysis has revealed that the aqueous extract contains free acids and steroid-type saponins, while the alcoholic extract contains alkaloids, tannins, and triterpenoid-type saponins[4]. Recent studies have shown high flavonoid content in purified extracts of T. crispa stem[5]. ## Traditional Uses and Therapeutic Applications Tinospora crispa extract has been traditionally used for treating numerous health conditions including: - Jaundice - Rheumatism and rheumatoid arthritis - Urinary disorders - Fever and malaria - Diabetes - Internal inflammation - Fracture - Scabies - Hypertension - Reducing thirst - Increasing appetite - Cooling body temperature - Maintaining general health[2] ## Pharmacological Activities Research has demonstrated that Tinospora crispa extract possesses various pharmacological properties: - Anti-inflammatory effects - Antioxidant activity - Immunomodulatory properties - Cytotoxic effects - Antimalarial activity - Cardioprotective benefits - Anti-diabetic properties[2] A recent study specifically showed that purified extract of T. crispa stem at a dose of 100 mg/kg demonstrated significant uric acid-lowering effects, suggesting potential applications in treating hyperuricemia and gout[5]. ## Safety Considerations While traditional use is widespread, there are some safety concerns to be aware of: - Hepatotoxicity has been reported with Tinospora crispa, which is medicinally interchangeable with the related species Tinospora cordifolia[1] - More elaborate toxicity studies are needed to ensure safety for human use[2] - Clinical trials are encouraged but should only be conducted when sufficient preclinical and safety data are available[2] ## Research Status Most pharmacological studies on Tinospora crispa have been conducted using crude extracts, and the specific bioactive compounds responsible for its therapeutic effects have not been well identified[2]. Further investigations are needed to transform traditional medicine claims into evidence-based information, including: - Qualitative and quantitative analysis of biomarkers in extracts used for studies - Detailed in vitro and in vivo studies on mechanisms of action - More comprehensive toxicity studies - Additional clinical trials when safety data is sufficient[2]

02

Targets

PXR (Pregnane X receptor)CYP2D6 (Cytochrome P450 2D6)CYP2C9 (Cytochrome P450 family 2 subfamily C member 9)TLR4 (Toll-like receptor 4)NF-κBCYP3A4 (Cytochrome P450 3A4)MEKMYD88 (Myeloid differentiation primary response protein MyD88)CYP2E1

Beyond the preview

Go deeper on Tinospora crispa extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tinospora crispa extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call